Живи долго! Научный подход к долгой молодости и здоровью - Майкл Грегер

742

del Castillo MD, Iriondo-DeHond A, Iriondo-DeHond M, et al. Healthy eating recommendations: good for reducing dietary contribution to the body’s advanced glycation/lipoxidation end products pool? Nutr Res Rev. 2021;34(1):48–63. https://pubmed.ncbi.nlm.nih.gov/32450931/

743

Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12. https://pubmed.ncbi.nlm.nih.gov/20497781/

744

Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12. https://pubmed.ncbi.nlm.nih.gov/20497781/

745

Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12. https://pubmed.ncbi.nlm.nih.gov/20497781/

746

Rungratanawanich W, Qu Y, Wang X, Essa MM, Song BJ. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med. 2021;53(2):168–88. https://pubmed.ncbi.nlm.nih.gov/33568752/

747

Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12. https://pubmed.ncbi.nlm.nih.gov/20497781/

748

Davis KE, Prasad C, Vijayagopal P, Juma S, Adams-Huet B, Imrhan V. Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat. Br J Nutr. 2015;114(11):1797–806. https://pubmed.ncbi.nlm.nih.gov/26392152/

749

Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65A(9):963–75. https://pubmed.ncbi.nlm.nih.gov/20478906/

750

Senolt L, Braun M, Olejarova M, Forejtova S, Gatterova J, Pavelka K. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis. 2005;64(6):886–90. https://pubmed.ncbi.nlm.nih.gov/15897309/

751

Hein G, Wiegand R, Lehmann G, Stein G, Franke S. Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology (Oxford). 2003;42(10):1242–6. https://pubmed.ncbi.nlm.nih.gov/12777635/

752

Meerwaldt R, Graaff R, Oomen PHN, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004;47(7):1324–30. https://pubmed.ncbi.nlm.nih.gov/15243705/

753

Mahmoudi R, Jaisson S, Badr S, et al. Post-translational modification-derived products are associated with frailty status in elderly subjects. Clin Chem Lab Med. 2019;57(8):1153–61. https://pubmed.ncbi.nlm.nih.gov/30817296/

754

Cavero-Redondo I, Soriano-Cano A, Álvarez-Bueno C, et al. Skin autofluorescence – indicated advanced glycation end products as predictors of cardiovascular and all-cause mortality in high-risk subjects: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(18):e009833. https://pubmed.ncbi.nlm.nih.gov/30371199/

755

Igase M, Ohara M, Igase K, et al. Skin autofluorescence examination as a diagnostic tool for mild cognitive impairment in healthy people. J Alzheimers Dis. 2017;55(4):1481–7. https://pubmed.ncbi.nlm.nih.gov/27858716/

756

Cai W, Uribarri J, Zhu L, et al. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A. 2014;111(13):4940–5. https://pubmed.ncbi.nlm.nih.gov/24567379/

757

Giem P, Beeson WL, Fraser GE. The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study. Neuroepidemiology. 1993;12(1):28–36. https://pubmed.ncbi.nlm.nih.gov/8327020/

758

Cao GY, Li M, Han L, et al. Dietary fat intake and cognitive function among older populations: a systematic review and meta-analysis. J Prev Alzheimers Dis. 2019;6(3):204–11. https://pubmed.ncbi.nlm.nih.gov/31062836/

759

Holloway CJ, Cochlin LE, Emmanuel Y, et al. A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects. Am J Clin Nutr. 2011;93(4):748–55. https://pubmed.ncbi.nlm.nih.gov/21270386/

760

Cai W, He JC, Zhu L, et al. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol. 2007;170(6):1893–902. https://pubmed.ncbi.nlm.nih.gov/17525257/

761

Akhter F, Chen D, Akhter A, et al. High dietary advanced glycation end products impair mitochondrial and cognitive function. J Alzheimers Dis. 2020;76(1):165–78. https://pubmed.ncbi.nlm.nih.gov/32444539/

762

Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes. 2003;52(6):1441–8. https://pubmed.ncbi.nlm.nih.gov/12765955/

763

Tsakiri EN, Iliaki KK, Höhn A, et al. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Free Radic Biol Med. 2013;65:1155–63. https://pubmed.ncbi.nlm.nih.gov/23999505/

764

Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes. 2003;52(6):1441–8. https://pubmed.ncbi.nlm.nih.gov/12765955/

765

Cai W, He JC, Zhu L, et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol. 2008;173(2):327–36. https://pubmed.ncbi.nlm.nih.gov/18599606/

766

Negrean M, Stirban A, Stratmann B, et al. Effects of low– and high-advanced glycation endproduct meals on macro-and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2007;85(5):1236–43. https://pubmed.ncbi.nlm.nih.gov/17490958/

767

. Šebeková K, Brouder Šebeková K. Glycated proteins in nutrition: friend or foe? Exp Gerontol. 2019;117:76–90. https://pubmed.ncbi.nlm.nih.gov/30458224/

768

. Šebeková K, Brouder Šebeková K. Glycated proteins in nutrition: friend or foe? Exp Gerontol. 2019;117:76–90. https://pubmed.ncbi.nlm.nih.gov/30458224/

769

Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008;31(12):2281–3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584181/

770

Gaesser GA, Rodriguez J, Patrie JT,